Dissecting racial disparities in multiple myeloma

CR Marinac, IM Ghobrial, BM Birmann, J Soiffer… - Blood cancer …, 2020 - nature.com
Multiple myeloma (MM) is a fatal plasma cell dyscrasia with a median overall survival of 5 to
10 years. MM progresses from the more common but often subclinical precursor states of …

[HTML][HTML] Socioeconomic status is globally a prognostic factor for overall survival of multiple myeloma patients: synthesis of studies and review of the literature

S Intzes, M Symeonidou, K Zagoridis… - … of Hematology and …, 2021 - ncbi.nlm.nih.gov
Background Socioeconomic status (SES) is reflecting differences in sociodemographic
factors affecting cancer survivorship. Deprived, low SES populations have a higher …

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

S Ailawadhi, S Jacobus, R Sexton, AK Stewart… - Blood cancer …, 2018 - nature.com
Multiple myeloma (MM) is an incurable hematologic malignancy with disparities in outcomes
noted among racial-ethnic subgroups, likely due to disparities in access to effective …

Global disparities in patients with multiple myeloma: a rapid evidence assessment

MV Mateos, S Ailawadhi, LJ Costa, SJ Grant… - Blood cancer …, 2023 - nature.com
There are disparities in outcomes for patients with multiple myeloma (MM). We evaluated the
influence of sociodemographic factors on global disparities in outcomes for patients with …

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities

S Ailawadhi, RD Frank, M Sharma, R Menghani… - Cancer, 2018 - Wiley Online Library
BACKGROUND Outcomes have improved significantly in multiple myeloma (MM), but racial
disparities in health care access and survival exist. A comprehensive analysis exploring MM …

Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis

S Ailawadhi, S Jagannath, HC Lee, M Narang… - Cancer, 2020 - Wiley Online Library
Background Studies have reported racial disparities in access to and use of multiple
myeloma (MM) treatments between African American (AA) and White patients. Although AA …

Education level as a predictor of survival in patients with multiple myeloma

L Xu, X Wang, X Pan, X Wang, Q Wang, B Wu, J Cai… - BMC cancer, 2020 - Springer
Background Disparities in multiple myeloma (MM) prognosis based on sociodemographic
factors may exist. We investigated whether education level at diagnosis influenced Chinese …

[HTML][HTML] Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma

TT Jayakrishnan, V Bakalov, Z Chahine, J Lister… - … /Oncology and Stem Cell …, 2021 - Elsevier
Background Disparities driven by socioeconomic factors have been shown to impact
outcomes for cancer patients. We sought to explore this relationship among patients with …

Many shades of disparities in myeloma care

S Ganguly, S Mailankody, S Ailawadhi - American Society of clinical …, 2019 - ascopubs.org
Treatment of multiple myeloma (MM) has notably evolved with improved patient outcomes
over the past few years. Several new drugs have become available, and large national and …

Multisite quality improvement initiative to identify and address racial disparities and deficiencies in delivering equitable, patient-centered care for multiple myeloma …

JR Mikhael, SL Sullivan, JD Carter, CL Heggen… - Current …, 2023 - mdpi.com
Treatment of multiple myeloma (MM) is complex; however, with equal access to care, clinical
outcomes for Black patients match those in other patient groups. To reveal and begin to …